1. Boehringer Ingelheim International Gmbh (14 from 1,536 patents)

2. Boehringer Ingelheim Pharma Kg (10 from 149 patents)

3. Dr. Karl Thomae Gmbh (9 from 133 patents)

4. Boehringer Ingelheim Pharma Gmbh & Co Kg (3 from 194 patents)

5. Karl Thomae Gmbh (3 from 36 patents)

6. Boehringer Ingelheim Kg (2 from 197 patents)

7. Boehringer Ingelehim Pharma Kg (1 from 1 patent)

1. 10189776 - Stereoselective process

2. 9670166 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

3. 9657015 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

4. 9475779 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

5. 9458113 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

6. 9440930 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

7. 9290459 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

8. 8551987 - Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate difumarate

9. 8420809 - Process for the manufacturing of betamimetics

10. 8222402 - Preparation process

11. 7939658 - Enantiomeric pure beta agonists, manufacturing and use as a medicaments thereof

12. 7696346 - Production method

13. 7638625 - Crystalline compounds

14. 7534789 - Enantiomeric pure β agonists, manufacturing and use as a medicament thereof

15. 7429597 - Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions